Skip to main content
SpringerLink
Log in

Clinical and prognostic significance of Yes-associated protein in colorectal cancer

  • Research Article
  • Published:
Tumor Biology

Abstract

The Hippo signaling pathway is a critical regulator of organ size control during development, and its deregulation is associated with cancers. Acting downstream of this pathway, Yes-associated protein (YAP) was implicated in tumorigenesis. The present study aimed to explore the expression patterns and clinical significance of YAP in human colorectal cancer (CRC). In addition, we investigated the relationship between YAP expression and Wnt/β-catenin pathway activation in CRC. A total of 139 cases of CRC tissues were investigated by immunohistochemistry for the expression of YAP, cyclin D1, and β-catenin. The association between YAP expression and clinicopathologic features was analyzed. Our results showed that YAP was overexpressed in 52.5 % (73/139) cases of CRC and predominantly presented in the nucleus. There was an excellent correlation between YAP expression and pTNM stage (p = 0.0024). YAP expression in CRC was significantly correlated with nodal status (p = 0.0034), tumor status (p = 0.0382), and cyclin D1 overexpression (p < 0.0001). Importantly, YAP expression was associated with short overall survival (p < 0.001). Furthermore, patients with YAP-positive and nuclear β-catenin-positive profiles had worse overall survival. Univariate and multivariate analyses revealed that YAP expression was an independent prognostic indicator of CRC (p = 0.0207). Our results indicated that YAP overexpression contributed to the tumorigenesis and played a pivotal role in the progression in CRC, and the interaction of YAP and Wnt/β-catenin pathways needs further exploration.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3

Similar content being viewed by others

References

  1. Zhao B et al. The Hippo-YAP pathway in organ size control and tumorigenesis: an updated version. Genes Dev. 2010;24(9):862–74.

    Article  PubMed  CAS  Google Scholar 

  2. Dong J et al. Elucidation of a universal size-control mechanism in Drosophila and mammals. Cell. 2007;130(6):1120–33.

    Article  PubMed  CAS  Google Scholar 

  3. Hanahan D, Weinberg RA. The hallmarks of cancer. Cell. 2000;100(1):57–70.

    Article  PubMed  CAS  Google Scholar 

  4. Huang J et al. The Hippo signaling pathway coordinately regulates cell proliferation and apoptosis by inactivating Yorkie, the Drosophila homolog of YAP. Cell. 2005;122(3):421–34.

    Article  PubMed  CAS  Google Scholar 

  5. Wu S et al. Hippo encodes a Ste-20 family protein kinase that restricts cell proliferation and promotes apoptosis in conjunction with salvador and warts. Cell. 2003;114(4):445–56.

    Article  PubMed  CAS  Google Scholar 

  6. Edgar BA. From cell structure to transcription: Hippo forges a new path. Cell. 2006;124(2):267–73.

    Article  PubMed  CAS  Google Scholar 

  7. Pan D. Hippo signaling in organ size control. Genes Dev. 2007;21(8):886–97.

    Article  PubMed  CAS  Google Scholar 

  8. Zhao B et al. Inactivation of YAP oncoprotein by the Hippo pathway is involved in cell contact inhibition and tissue growth control. Genes Dev. 2007;21(21):2747–61.

    Article  PubMed  CAS  Google Scholar 

  9. Overholtzer M et al. Transforming properties of YAP, a candidate oncogene on the chromosome 11q22 amplicon. Proc Natl Acad Sci U S A. 2006;103(33):12405–10.

    Article  PubMed  CAS  Google Scholar 

  10. Zender L et al. Identification and validation of oncogenes in liver cancer using an integrative oncogenomic approach. Cell. 2006;125(7):1253–67.

    Article  PubMed  CAS  Google Scholar 

  11. Espanel X, Sudol M. Yes-associated protein and p53-binding protein-2 interact through their WW and SH3 domains. J Biol Chem. 2001;276(17):14514–23.

    PubMed  CAS  Google Scholar 

  12. Howell M, Borchers C, Milgram SL. Heterogeneous nuclear ribonuclear protein U associates with YAP and regulates its co-activation of Bax transcription. J Biol Chem. 2004;279(25):26300–6.

    Article  PubMed  CAS  Google Scholar 

  13. Komuro A et al. WW domain-containing protein YAP associates with ErbB-4 and acts as a co-transcriptional activator for the carboxyl-terminal fragment of ErbB-4 that translocates to the nucleus. J Biol Chem. 2003;278(35):33334–41.

    Article  PubMed  CAS  Google Scholar 

  14. Strano S et al. The transcriptional coactivator Yes-associated protein drives p73 gene-target specificity in response to DNA damage. Mol Cell. 2005;18(4):447–59.

    Article  PubMed  CAS  Google Scholar 

  15. Strano S et al. Physical interaction with Yes-associated protein enhances p73 transcriptional activity. J Biol Chem. 2001;276(18):15164–73.

    Article  PubMed  CAS  Google Scholar 

  16. Yagi R et al. A WW domain-containing yes-associated protein (YAP) is a novel transcriptional co-activator. EMBO J. 1999;18(9):2551–62.

    Article  PubMed  CAS  Google Scholar 

  17. Zaidi SK et al. Tyrosine phosphorylation controls Runx2-mediated subnuclear targeting of YAP to repress transcription. EMBO J. 2004;23(4):790–9.

    Article  PubMed  CAS  Google Scholar 

  18. Zhao B et al. TEAD mediates YAP-dependent gene induction and growth control. Genes Dev. 2008;22(14):1962–71.

    Article  PubMed  CAS  Google Scholar 

  19. Baldwin C et al. Multiple microalterations detected at high frequency in oral cancer. Cancer Res. 2005;65(17):7561–7.

    PubMed  CAS  Google Scholar 

  20. Fernandez LA et al. YAP1 is amplified and up-regulated in hedgehog-associated medulloblastomas and mediates Sonic hedgehog-driven neural precursor proliferation. Genes Dev. 2009;23(23):2729–41.

    Article  Google Scholar 

  21. Modena P et al. Identification of tumor-specific molecular signatures in intracranial ependymoma and association with clinical characteristics. J Clin Oncol. 2006;24(33):5223–33.

    Article  PubMed  CAS  Google Scholar 

  22. Snijders AM et al. Rare amplicons implicate frequent deregulation of cell fate specification pathways in oral squamous cell carcinoma. Oncogene. 2005;24(26):4232–42.

    Article  PubMed  CAS  Google Scholar 

  23. Steinhardt AA et al. Expression of Yes-associated protein in common solid tumors. Hum Pathol. 2008;39(11):1582–9.

    Article  PubMed  CAS  Google Scholar 

  24. Wang Y et al. Overexpression of yes-associated protein contributes to progression and poor prognosis of non-small-cell lung cancer. Cancer Sci. 2010;101(5):1279–85.

    Article  PubMed  CAS  Google Scholar 

  25. Xu MZ et al. Yes-associated protein is an independent prognostic marker in hepatocellular carcinoma. Cancer. 2009;115(19):4576–85.

    Article  PubMed  CAS  Google Scholar 

  26. Camargo FD et al. YAP1 increases organ size and expands undifferentiated progenitor cells. Curr Biol. 2007;17(23):2054–60.

    Article  PubMed  CAS  Google Scholar 

  27. Jemal A, et al. Cancer statistics. CA Cancer J Clin.2010.

  28. Klaus A, Birchmeier W. Wnt signalling and its impact on development and cancer. Nat Rev Cancer. 2008;8(5):387–98.

    Article  PubMed  CAS  Google Scholar 

  29. Avruch J, Zhou D, Bardeesy N. YAP oncogene overexpression supercharges colon cancer proliferation. Cell Cycle. 2012;11(6):1090–6.

    Article  PubMed  CAS  Google Scholar 

  30. Zhou D et al. Mst1 and Mst2 protein kinases restrain intestinal stem cell proliferation and colonic tumorigenesis by inhibition of Yes-associated protein (Yap) overabundance. Proc Natl Acad Sci U S A. 2011;108(49):E1312–20.

    Article  PubMed  CAS  Google Scholar 

  31. Konsavage Jr WM et al. Wnt/beta-catenin signaling regulates Yes-associated protein (YAP) gene expression in colorectal carcinoma cells. J Biol Chem. 2012;287(15):11730–9.

    Article  PubMed  CAS  Google Scholar 

  32. Ogino S et al. A cohort study of cyclin D1 expression and prognosis in 602 colon cancer cases. Clin Cancer Res. 2009;15(13):4431–8.

    Article  PubMed  CAS  Google Scholar 

  33. Cao X, Pfaff SL, Gage FH. YAP regulates neural progenitor cell number via the TEA domain transcription factor. Genes Dev. 2008;22(23):3320–34.

    Article  PubMed  CAS  Google Scholar 

  34. Clevers H. Wnt/beta-catenin signaling in development and disease. Cell. 2006;127(3):469–80.

    Article  PubMed  CAS  Google Scholar 

Download references

Conflicts of interest

No conflict of interest was disclosed in this article.

Author information

Authors and Affiliations

  1. Department of Pathology, First Affiliated Hospital and College of Basic Medical Sciences, China Medical University, North 2nd Road 92, Heping Ward, Shenyang, Liaoning Province, People’s Republic of China

    Yan Wang, Chengyao Xie, Qingchang Li & Enhua Wang

  2. Department of Radiology, First Affiliated Hospital of China Medical University, Shenyang, 110001, People’s Republic of China

    Ke Xu

Authors
  1. Yan Wang
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Chengyao Xie
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Qingchang Li
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Ke Xu
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Enhua Wang
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Yan Wang.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Wang, Y., Xie, C., Li, Q. et al. Clinical and prognostic significance of Yes-associated protein in colorectal cancer. Tumor Biol. 34, 2169–2174 (2013). https://doi.org/10.1007/s13277-013-0751-x

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s13277-013-0751-x

Keywords

Search

Navigation